Prime Medicine

November is #Alpha1AwarenessMonth.
This year's theme, "The Future of Alpha-1 is You," recognizes the patients, families, advocates, and researchers helping drive progress for the Alpha-1 community.

We're proud to stand with @AlphaFriend and support continued innovation for people living with Alpha-1 and other serious genetic diseases.

#Alpha1 #AATD #RareDisease #GeneticMedicine

FDA published draft guidance that could change how genetic medicines reach rare disease patients. Prime editing was designed for it: one platform, one delivery system Let’s get more medicines to patients in need.
fda.gov/media/195887/d…

We announced the first patient has been dosed in our global Phase 1/2 clinical trial of PM577a for H1069Q-mutated Wilson disease.
PM577 has also received FDA Rare Pediatric Disease designation.
Read more: tinyurl.com/mue7xe9e
#PrimeMedicine #WilsonDisease #GeneEditing

Thank you to @WilsonDiseaseA for an impactful Annual Conference. We valued connecting with patients, caregivers, advocates, healthcare professionals, and researchers to discuss Prime Editing and Prime-0201.

#WilsonDisease #RareDisease

The Prime team hit Blue Hills for a fall hike, led by our CMO, Mohammed Asmal, followed by a stop at Widowmaker Brewing. Great way to recharge together!
#TeamPrime #CompanyCulture